# US 2020/0369651 A1 · A process to obtain a tetrahydroisoquinoline derivative

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0369651 A1
- Document ID: US20200369651A1
- Status: Published application
- Kind: A1
- Application number: 16/764,795
- Filed: 2018-11-16
- Published: 2020-11-26
- Earliest claimed: 2017-11-17
- Assignees: Medichem, S.A.
- Applicants: Medichem S.A.
- Inventors: Zhu BIN; Rao LINGXIANG; Jordi PUIG SERRANO; Ernesto DURÁN LÓPEZ
- Web page: https://patentgrep.com/patent/US20200369651A1

## CPC

- C07D 405/06: linked by a carbon chain containing only aliphatic carbon atoms
- B01J 23/44: Palladium
- C07D 217/06: with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS

## Abstract

The present invention relates to a process for preparing lifitegrast or a salt thereof, wherein the process comprises hydrogenation of compound II in a mixture comprising at least one solvent selected from the group consisting of acetonitrile, a ketone solvent, an ester solvent and a mixture thereof, preferably acetonitrile.

## Claims

### Claim 1

A process for preparing lifitegrast or a salt thereof, the process comprising hydrogenation of compound II
in a mixture comprising at least one solvent selected from the group consisting of acetonitrile, a ketone solvent, an ester solvent and a mixture thereof, preferably acetonitrile.

### Claim 2 (depends on 1)

The process according to claim 1, wherein the hydrogenation is a transfer hydrogenolysis catalyzed by palladium and in the presence of formic acid or a salt thereof as a hydrogen donor.

### Claim 3 (depends on 2)

The process according to claim 2, wherein the hydrogen donor is triethylammonium formate.

### Claim 4 (depends on 1)

The process according to claim 1, wherein the ketone solvent is selected from the group consisting of acetone, methyl butyl ketone, methyl ethyl ketone, methyl isobutyl ketone, methyl isopropyl ketone and a mixture thereof, and the ester solvent is selected from the group consisting of butyl acetate, ethyl acetate, ethyl formate, isobutyl acetate, isopropyl acetate, methyl acetate, methyl formate, propyl acetate and a mixture thereof.

### Claim 5 (depends on 1)

The process according to claim 1, wherein the hydrogenation is performed in the presence of a chloride salt.

### Claim 6 (depends on 5)

The process according to claim 5, wherein the chloride salt is an ammonium chloride salt, preferably tetrabutylammonium chloride.

### Claim 7 (depends on 1)

The process according to claim 1, wherein the process comprises:
(a) reacting compound III
or a salt thereof with 1,1′-carbonyldiimidazole (CDI) to obtain an activated derivative of compound III; and
(b) reacting the activated derivative of compound III of step (a) with compound IV
or a salt thereof, to obtain compound II

### Claim 8 (depends on 7)

The process according to claim 7, wherein the reaction to obtain compound II is performed in a solvent selected from the group consisting of butyl acetate, ethyl acetate, ethyl formate, isobutyl acetate, isopropyl acetate, methyl acetate, methyl formate, propyl acetate, dimethylsulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide and a mixture thereof, preferably in a mixture comprising ethyl acetate and dimethylsulfoxide.

### Claim 9 (depends on 7)

The process according to claim 7, wherein the process comprises deprotecting the compound of formula V
to obtain compound IV
or a salt thereof.

### Claim 10 (depends on 9)

The process according to claim 9, wherein the deprotection is performed using hydrogen chloride and in a solvent selected from the group consisting of butyl acetate, ethyl acetate, ethyl formate, isobutyl acetate, isopropyl acetate, methyl acetate, methyl formate, propyl acetate and a mixture thereof, preferably butyl acetate.

### Claim 11 (depends on 9)

The process according to claim 9, wherein the process comprises:
(c) reacting compound VII
or a salt thereof with oxalyl chloride to obtain an activated derivative of compound VII; and
(d) reacting the activated derivative of compound VII of step (c) with compound VI
or a salt thereof, to obtain compound V

### Claim 12 (depends on 11)

The process according to claim 11, wherein the reaction to obtain compound V is performed in a solvent selected from the group consisting of butyl acetate, ethyl acetate, ethyl formate, isobutyl acetate, isopropyl acetate, methyl acetate, methyl formate, propyl acetate, dimethylsulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide and a mixture thereof, preferably in a mixture comprising butyl acetate and N,N-dimethylformamide.

### Claim 13

(canceled)

### Claim 14

(canceled)

### Claim 15

(canceled)

### Claim 16 (depends on 1)

The process according to claim 1, wherein the hydrogenation is a transfer hydrogenolysis catalyzed by palladium and in the presence of formic acid or a salt thereof as a hydrogen donor; and the ketone solvent is selected from the group consisting of acetone, methyl butyl ketone, methyl ethyl ketone, methyl isobutyl ketone, methyl isopropyl ketone and a mixture thereof, and the ester solvent is selected from the group consisting of butyl acetate, ethyl acetate, ethyl formate, isobutyl acetate, isopropyl acetate, methyl acetate, methyl formate, propyl acetate and a mixture thereof.

### Claim 17 (depends on 16)

The process according to claim 16, wherein the hydrogen donor is triethylammonium formate.

### Claim 18 (depends on 17)

The process according to claim 17, wherein the hydrogenation is performed in the presence of a chloride salt.

### Claim 19 (depends on 1)

The process according to claim 1, wherein the hydrogenation is a transfer hydrogenolysis catalyzed by palladium and in the presence of formic acid or a salt thereof as a hydrogen donor; and the hydrogenation is performed in the presence of a chloride salt.

### Claim 20 (depends on 9)

The process according to claim 9, wherein the deprotection is performed using hydrogen chloride and in a solvent selected from the group consisting of butyl acetate, ethyl acetate, ethyl formate, isobutyl acetate, isopropyl acetate, methyl acetate, methyl formate, propyl acetate and a mixture thereof, preferably butyl acetate; and the process comprises:
(c) reacting compound VII
or a salt thereof with oxalyl chloride to obtain an activated derivative of compound VII; and
(d) reacting the activated derivative of compound VII of step (c) with compound VI
or a salt thereof, to obtain compound V
